General Information of Drug (ID: DMGE8FK)

Drug Name
AMR-001 Drug Info
Indication
Disease Entry ICD 11 Status REF
Heart failure BD10-BD13 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMGE8FK

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Preclinical Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
CART-34 cells DMRNIB9 Acute myeloid leukaemia 2A60 Phase 1 [3]
CAR-T cells targeting CD34 DM3G0OP Acute myeloid leukaemia 2A60 Preclinical [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hematopoietic progenitor cell antigen CD34 (CD34) TTZAVYN CD34_HUMAN Modulator [2]

References

1 ClinicalTrials.gov (NCT01495364) NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction. U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug id 743421).
3 ClinicalTrials.gov (NCT03291444) CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS
4 ClinicalTrials.gov (NCT03473457) CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia